Empagliflozin Treatment Is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes
Sodium–glucose cotransporter 2 (SGLT2) inhibitors reduce the risk of major adverse cardiovascular (CV) events and hospitalization for heart failure (HF) in patients with type 2 diabetes (T2D). Using CV MRI (CMR) and 31P-MRS in a longitudinal cohort study, we aimed to investigate the effects of the s...
Uloženo v:
Hlavní autoři: | Sharmaine Thirunavukarasu, Nicholas Jex, Amrit Chowdhary, Imtiaz Ul Hassan, Sam Straw, Thomas P. Craven, Miroslawa Gorecka, David A. Broadbent, Peter Swoboda, Klaus K. Witte, Richard M. Cubbon, Hui Xue, Peter Kellman, John P. Greenwood, Sven Plein, Eylem Levelt |
---|---|
Médium: | Artigo |
Jazyk: | angličtina |
Vydáno: |
2021
|
On-line přístup: | https://doi.org/10.2337/db21-0270 https://diabetesjournals.org/diabetes/article-pdf/70/12/2810/634595/db210270.pdf |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
Podobné jednotky
-
Empagliflozin Treatment Is Associated With Improvements in Cardiac Energetics and Function and Reductions in Myocardial Cellular Volume in Patients With Type 2 Diabetes
Autor: Thirunavukarasu, Sharmaine, a další
Vydáno: (2021) -
Coronary microvascular function and visceral adiposity in patients with normal body weight and type 2 diabetes
Autor: Chowdhary, Amrit, a další
Vydáno: (2022) -
Rationale and design of the randomised controlled cross-over trial: Cardiovascular effects of empaglifozin in diabetes mellitus
Autor: Thirunavukarasu, Sharmaine, a další
Vydáno: (2021) -
Global microvascular ischaemia following Takotsubo cardiomyopathy with left ventricular function recovery
Autor: Chowdhary, Amrit, a další
Vydáno: (2021) -
Multiple Etiologies to Myocardial Injury in COVID-19
Autor: Gorecka, Miroslawa, a další
Vydáno: (2021)